Table 1 Unadjusted odd ratios (95% CI) and the prevalence of IgG antibodies against HSV-1, Chlamydia pneumoniae, HSV-1 and H. pylori among men & women with and without the metabolic syndrome; the Persian Gulf Healthy Heart Study
Male | Female | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Metabolic Syndrome | Healthy | O.R* | C.I† | p value | Metabolic Syndrome | Healthy | O.R | C.I | p value | |
HSV-1‡ | 84.2% | 83.3% | 1.06 | 0.73–1.54 | N.S | 92.1% | 85.3% | 2.01 | 1.27–3.16 | 0.003 |
CMV§ | 94.3% | 89.2% | 1.99 | 1.121–3.27 | 0.007 | 94.8% | 93.6% | 1.23 | 0.7–2.15 | N.S |
Chlamydia pneumoniae | 51.9% | 37.8% | 1.77 | 1.34–2.32 | 0.0001 | 42.2% | 30.0% | 1.69 | 1.28–2.23 | 0.0001 |
H. pylori** | 67.9% | 56.6% | 1.62 | 1.23–2.13 | 0.001 | 64.4% | 55.1% | 1.47 | 1.12–1.92 | 0.004 |